Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does HGV-HIV co-infection exist?

E Pontali1, P Pedemonte, M Bassetti

  • 1Department of Infectious Diseases, University of Genoa, Largo G. Gaslini, 5, 16147, Genova, Italy. pontals@yahoo.com

International Journal of Antimicrobial Agents
|November 25, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of persistence of Candidozyma auris colonization.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Antimicrobial resistance and gene therapy: emerging molecular strategies for a global health threat.

Gene therapy·2026
Same author

Perforated Mooren's ulcer in African melanoderm: Report of 18 cases.

Journal francais d'ophtalmologie·2026
Same author

Immunogenicity and safety of two doses of the four-component recombinant meningococcal B (4CMenB) vaccine in adults with immunodeficiency.

Vaccine·2026
Same author

A network between infectious diseases department and general practitioners for COVID-19 patients: towards a strengthened link?

Journal of chemotherapy (Florence, Italy)·2025
Same author

The Importance of Early Mycological Clearance of Uncomplicated Candidaemia and Its Implications for Clinical Practice.

Mycoses·2025
Same journal

Machine Learning-Based Drug Susceptibility Prediction from Candida Genomic Data.

International journal of antimicrobial agents·2026
Same journal

Vancomycin Penetration into Intra-abdominal Compartments: Site Concentration Disparities and Implications for Dose Optimization in Gram-Positive Infections.

International journal of antimicrobial agents·2026
Same journal

Strain-dependent variability in pharmacodynamic interactions for phage-antibiotic combinations in Pseudomonas aeruginosa.

International journal of antimicrobial agents·2026
Same journal

Carbapenem-resistant Enterobacterales across the UK: a nationwide study of carbapenemase testing and novel antimicrobial activity.

International journal of antimicrobial agents·2026
Same journal

Kidney Injury, Dialysis, and Mortality with Vancomycin Plus Piperacillin-Tazobactam or Cefepime.

International journal of antimicrobial agents·2026
Same journal

Ceftaroline pharmacokinetics on ECMO, a pediatric case report.

International journal of antimicrobial agents·2026
See all related articles

Hepatitis G virus (HGV) active infection is rare in HIV-1-infected children, with prevalence less than 2.7% in this cohort. Despite risk factors, no children showed signs of HGV infection.

Area of Science:

  • Virology
  • Infectious Diseases
  • Pediatrics

Background:

  • Hepatitis G virus (HGV), a Flaviviridae family member, has shown varying prevalence in Human Immunodeficiency Virus type 1 (HIV-1) infected populations.
  • Understanding HGV coinfection in pediatric HIV-1 is crucial for comprehensive patient management.

Purpose of the Study:

  • To determine the prevalence of active Hepatitis G virus infection in a cohort of children with HIV-1 infection.
  • To assess the presence of HGV-RNA in pediatric HIV-1 patients.

Main Methods:

  • Retrospective analysis of HGV-RNA in a cohort of HIV-1-infected children.
  • Evaluation of risk factors associated with HGV infection in the study population.

Main Results:

Related Experiment Videos

  • No children in the cohort presented with detectable HGV-RNA, indicating no active Hepatitis G virus infection.
  • The prevalence of active HGV infection was calculated to be less than 2.7% within this pediatric cohort.
  • Despite the presence of potential risk factors for HGV transmission, active infection was not observed.

    • Conclusions:

    • Active Hepatitis G virus infection is uncommon in this cohort of HIV-1-infected children.
    • The low prevalence suggests that HGV may not be a significant coinfection concern in pediatric HIV-1 patients in this setting.